Home LiteratureArticle Details
PMID: 14532148 Published · ppublish English Journal Article Review

Metalloproteinases, inflammation, and rheumatoid arthritis.

Annals of the rheumatic diseases ·Vol. 62 Suppl 2 ·2003-11-00 ·Pages ii43-7

Mohammed FF, Smookler DS, Khokha R

Abstract

Ideally, the inflammatory response occurs rapidly to terminate infection. It also must halt in a timely manner to stop this reaction from inflicting self damage. Such a highly regulated process results from altering balances in pro- and anti-inflammatory signals orchestrated by multiple cell types and factors within the tissue microenvironment. The discovery of new substrates of metalloproteinases within this microenvironment has disclosed a new function in inflammation. The role of these proteases now extends beyond extracellular matrix remodelling enzymes to that of mediators of inflammatory signals involving various chemokines and cytokines. As natural inhibitors of these metalloproteinases, TIMPs have the potential of regulating the inflammatory response and affecting diseases such as rheumatoid arthritis. TIMP-3, in particular, stands out as an important regulator of inflammation with its ability to specifically inhibit proinflammatory cytokines and tissue destruction in the joint.

MeSH Terms
Arthritis, Rheumatoid/physiopathology Humans Inflammation/physiopathology Inflammation Mediators/physiology Metalloproteases/physiology Tissue Inhibitor of Metalloproteinase-3/physiology
Chemicals
Inflammation Mediators Tissue Inhibitor of Metalloproteinase-3 Metalloproteases
Authors & Affiliations
3 authors, click to expand affiliations / ORCID
Mohammed F F
Ontario Cancer Institute/University Health Network, Toronto, Canada.
Smookler D S
Khokha R
References (32)
32 references, click to expand
  1. Tissue inhibitors of metalloproteinases: evolution, structure and function.
    Biochim Biophys Acta. 2000 Mar 7;1477(1-2):267-83 PMID: 10708863
  2. Regulation of intestinal alpha-defensin activation by the metalloproteinase matrilysin in innate host defense.
    Science. 1999 Oct 1;286(5437):113-7 PMID: 10506557
  3. Inflammation dampened by gelatinase A cleavage of monocyte chemoattractant protein-3.
    Science. 2000 Aug 18;289(5482):1202-6 PMID: 10947989
  4. Matrix metalloproteinases: effectors of development and normal physiology.
    Genes Dev. 2000 Sep 1;14(17):2123-33 PMID: 10970876
  5. TIMP-3 binds to sulfated glycosaminoglycans of the extracellular matrix.
    J Biol Chem. 2000 Oct 6;275(40):31226-32 PMID: 10900194
  6. TIMP-3 is a potent inhibitor of aggrecanase 1 (ADAM-TS4) and aggrecanase 2 (ADAM-TS5).
    J Biol Chem. 2001 Apr 20;276(16):12501-4 PMID: 11278243
  7. Physiology of cytokine pathways in rheumatoid arthritis.
    Arthritis Rheum. 2001 Feb;45(1):101-6 PMID: 11308054
  8. Inhibition of ADAMTS4 (aggrecanase-1) by tissue inhibitors of metalloproteinases (TIMP-1, 2, 3 and 4).
    FEBS Lett. 2001 Apr 13;494(3):192-5 PMID: 11311239
  9. Fractalkine, a novel chemokine in rheumatoid arthritis and in rat adjuvant-induced arthritis.
    Arthritis Rheum. 2001 Jul;44(7):1568-81 PMID: 11465708
  10. Tumor necrosis factor-alpha-converting enzyme (ADAM17) mediates the cleavage and shedding of fractalkine (CX3CL1).
    J Biol Chem. 2001 Oct 12;276(41):37993-8001 PMID: 11495925
  11. Matrix metalloproteinase activity inactivates the CXC chemokine stromal cell-derived factor-1.
    J Biol Chem. 2001 Nov 23;276(47):43503-8 PMID: 11571304
  12. Articular cartilage and changes in arthritis: matrix degradation.
    Arthritis Res. 2001;3(6):337-41 PMID: 11714387
  13. Matrix metalloproteinases in arthritic disease.
    Arthritis Res. 2002;4 Suppl 3:S39-49 PMID: 12110122
  14. Matrix metalloproteinase processing of monocyte chemoattractant proteins generates CC chemokine receptor antagonists with anti-inflammatory properties in vivo.
    Blood. 2002 Aug 15;100(4):1160-7 PMID: 12149192
  15. Matrilysin shedding of syndecan-1 regulates chemokine mobilization and transepithelial efflux of neutrophils in acute lung injury.
    Cell. 2002 Nov 27;111(5):635-46 PMID: 12464176
  16. Points of control in inflammation.
    Nature. 2002 Dec 19-26;420(6917):846-52 PMID: 12490957
  17. Inflammation and cancer.
    Nature. 2002 Dec 19-26;420(6917):860-7 PMID: 12490959
  18. Cartilage degradation and invasion by rheumatoid synovial fibroblasts is inhibited by gene transfer of TIMP-1 and TIMP-3.
    Gene Ther. 2003 Feb;10(3):234-42 PMID: 12571631
  19. Stabilization of the bioactivity of tumor necrosis factor by its soluble receptors.
    J Exp Med. 1992 Feb 1;175(2):323-9 PMID: 1310100
  20. Modulation of two forms of tumor necrosis factor receptors and their cellular response by soluble receptors and their monoclonal antibodies.
    J Biol Chem. 1992 Oct 15;267(29):20892-9 PMID: 1328214
  21. Mutations in the tissue inhibitor of metalloproteinases-3 (TIMP3) in patients with Sorsby's fundus dystrophy.
    Nat Genet. 1994 Dec;8(4):352-6 PMID: 7894485
  22. The gene structure of tissue inhibitor of metalloproteinases (TIMP)-3 and its inhibitory activities define the distinct TIMP gene family.
    J Biol Chem. 1995 Jun 16;270(24):14313-8 PMID: 7782289
  23. Biochemical characterization of human collagenase-3.
    J Biol Chem. 1996 Jan 19;271(3):1544-50 PMID: 8576151
  24. Modulation of proinflammatory cytokine release in rheumatoid synovial membrane cell cultures. Comparison of monoclonal anti TNF-alpha antibody with the interleukin-1 receptor antagonist.
    Eur Cytokine Netw. 1995 Jul-Dec;6(4):225-30 PMID: 8789287
  25. A metalloproteinase disintegrin that releases tumour-necrosis factor-alpha from cells.
    Nature. 1997 Feb 20;385(6618):729-33 PMID: 9034190
  26. Cloning of a disintegrin metalloproteinase that processes precursor tumour-necrosis factor-alpha.
    Nature. 1997 Feb 20;385(6618):733-6 PMID: 9034191
  27. Transcriptional control of matrix metalloproteinases and the tissue inhibitors of matrix metalloproteinases.
    Crit Rev Eukaryot Gene Expr. 1997;7(1-2):159-78 PMID: 9034720
  28. Localization of the functional domains of human tissue inhibitor of metalloproteinases-3 and the effects of a Sorsby's fundus dystrophy mutation.
    J Biol Chem. 1998 Jul 3;273(27):16778-81 PMID: 9642234
  29. Cytokine-induced cartilage proteoglycan degradation is mediated by aggrecanase.
    Osteoarthritis Cartilage. 1998 May;6(3):214-28 PMID: 9682788
  30. TNF-alpha converting enzyme (TACE) is inhibited by TIMP-3.
    FEBS Lett. 1998 Sep 11;435(1):39-44 PMID: 9755855
  31. IL-4 potentiates IL-1beta- and TNF-alpha-stimulated IL-8 and MCP-1 protein production in human retinal pigment epithelial cells.
    Curr Eye Res. 1999 May;18(5):349-57 PMID: 10372996
  32. Functional analysis of the domain structure of tumor necrosis factor-alpha converting enzyme.
    J Biol Chem. 2000 May 12;275(19):14608-14 PMID: 10799547
Article Info
Journal
Annals of the rheumatic diseases
Abbr.
Ann Rheum Dis
ISSN
0003-4967
Published
2003-11-00
Pages
ii43-7
Language
English
Region
England
NLM ID
0372355
PMCID
PMC1766743
Subset
IM
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com